Core Viewpoint - The company, Meili Tianyuan, is actively expanding its business through acquisitions, reporting significant revenue and profit growth in the first half of 2025, with a year-on-year revenue increase of at least 27% and a net profit increase of at least 35% [1][3]. Group 1: Financial Performance - Meili Tianyuan's revenue for the first half of 2025 is projected to reach a new high, potentially approaching 3 billion yuan for the full year [1]. - The company's revenue growth is attributed to its "Double Beauty + Double Health" business model, which has increased the proportion of high-margin business revenue [1][3]. - The company has maintained a dual strategy of "internal growth + external expansion," leading to increased scale and market share [1][3]. Group 2: Business Model and Strategy - The "Double Beauty + Double Health" model focuses on acquiring customers through beauty services and smart beauty maintenance, then offering medical beauty and sub-health medical services, with gross margins exceeding 50% for the latter [1][3]. - Following the acquisition of Nai Rui Er in 2024, the company has expanded its store count to over 554, with Nai Rui Er providing differentiated services such as acupuncture and traditional Chinese medicine [3][6]. - The company is actively working on converting beauty service customers to medical beauty and health services, with 24.9% of beauty and health members having consumed medical beauty or sub-health services by 2024 [8]. Group 3: Market Trends and Challenges - The overall growth rate of the beauty industry is showing signs of fatigue, prompting Meili Tianyuan to invest more in higher-margin medical beauty and health management services [6]. - The beauty industry remains highly fragmented, with the top five companies holding only 0.7% market share, indicating significant room for consolidation [10]. - The industry is trending towards specialization and segmentation, with emerging vertical brands focusing on specific technologies potentially threatening traditional large-scale beauty institutions [10]. Group 4: Operational Management - To ensure service quality across its expanding franchise network, Meili Tianyuan implements a "one-year contract" system for franchisees, with regular evaluations and quality control measures [11]. - The company faces challenges in maintaining consistent service quality across its franchise locations, as the nature of offline beauty services emphasizes service quality over product offerings [11].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of 37.36 HKD [6][7]. Core Views - The company is expected to achieve a revenue of at least 1.45 billion RMB in the first half of 2025, representing a year-on-year growth of 27%, and an adjusted net profit of at least 175 million RMB, reflecting a year-on-year increase of 33% [1][6]. - The company's business model, focusing on "Double Beauty + Double Health," is driving robust performance, with a 10% year-on-year increase in organic customer traffic for the first half of 2025 [1][2]. - The management's confidence in the company's long-term development is highlighted by a recent share buyback, which totaled 60,500 shares at an average price of approximately 29.12 HKD [3]. Summary by Sections Performance Forecast - The company has adjusted its net profit forecasts for 2025-2027 to 320 million, 369 million, and 420 million RMB respectively, with a compound annual growth rate (CAGR) of 22% [4][10]. - The expected earnings per share (EPS) for 2025, 2026, and 2027 are projected to be 1.36, 1.57, and 1.78 RMB respectively [4][10]. Revenue Structure - The board attributes the performance improvement to the continuous refinement of the "Double Beauty + Double Health" business model, which has led to an increase in the proportion of high-margin business revenue [2][10]. Market Position - The company is positioned as a leader in the beauty and health sector, actively optimizing shareholder structure and exploring acquisition opportunities to enhance market value [4][10].